Desogestrel And Ethinyl Estradiol Kit
Product Images NDC 51862-514

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol (NDC 51862-514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structures of Desogestrel and Ethinyl Estradiol are shown, each labeled accordingly with their molecular formulas C22H30O and C20H24O2 respectively. The structures illustrate the molecular arrangement of both active ingredients.*

FDA Label Image

Imgae-02 (Image 02)

A bar chart titled "Circulatory disease mortality rates per 100,000 women-years by age, smoking status, and oral contraceptive use." It displays mortality rates for four groups: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers) across four age groups (15-24, 25-34, 35-44, and 45+). The mortality rate increases significantly in the 45+ age group for ever-users who smoke.*

FDA Label Image

Image-03 (Image 03)

A warning text panel stating that desogestrel and ethinyl estradiol tablets should not be used by individuals who smoke cigarettes and are over 35 years old due to increased risk of serious cardiovascular side effects, such as heart attacks, blood clots, or strokes. The risk is said to increase with age and number of cigarettes smoked.*

FDA Label Image

Image-04 (Image 04)

An illustrated medication reminder card depicting a 28-day cycle with labeled rows for tracking daily pill intake. The card includes color indicators for "Orange (Active)" and "White (Inactive)" pills, arranged by day of the week from Sunday to Saturday. This example chart aids in organizing daily oral contraceptive use for Desogestrel and Ethinyl Estradiol.*

FDA Label Image

Image-05 (Image 05)

An instructional diagram showing how to use a Desogestrel and Ethinyl Estradiol oral contraceptive blister pack. The image depicts a hand lifting a day label strip above the pill pack, which contains rows of round tablets labeled by days of the week. Active and inactive pills are color-coded with orange for active and white for inactive, and an instruction to pick the correct day label and place it on the pack is included.*

FDA Label Image

Image-06 (Image 06)

A warning text panel advising not to use desogestrel and ethinyl estradiol tablets if smoking cigarettes and over 35 years old due to increased risk of serious cardiovascular side effects such as heart attack, blood clots, or stroke. It explains that this risk increases with age and the number of cigarettes smoked.*

FDA Label Image

Image-07 (Image 07)

Desogestrel and Ethinyl Estradiol 28 Tablet Starter Card kit by Mayne Pharma Inc. The image shows a weekly dosing card with circles arranged in columns for each day of the week (Sunday to Saturday). Active tablets are indicated as orange circles and inactive tablets as white circles. The card is designed for a 28-day oral contraceptive regimen.*

FDA Label Image

Image-08 (Image 08)

An instructional diagram showing a hand placing a day-of-the-week label strip on a dosage kit of Desogestrel and Ethinyl Estradiol tablets. The kit contains circular tablets arranged in rows, with orange tablets labeled as active and white tablets as inactive. The label strip includes days from Monday to Sunday to assist in tracking daily dosage.*

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Image-10 (Image 10)

Packaging label for Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg. The label identifies it as a prescription oral contraceptive product distributed by Mayne Pharma Inc., with each kit containing 3 blister cards of 28 tablets each. The label includes dosage form, strength, NDC 51862-514, warnings about use, and storage instructions.*

FDA Label Image

Image-11 (Image 11)

A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use, particularly in women over 35 years of age who smoke. It advises that combination oral contraceptives, including desogestrel and ethinyl estradiol tablets, should not be used by women over 35 years old who smoke.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.